EVALUATION OF TOCILIZUMAB ON CLINICAL OUTCOMES IN CRITICALLY ILL PATIENTS WITH COVID-19

被引：0
|
作者：
Swartwood, Claire [1 ]
Miller, Christopher [2 ]
North, Michael [2 ]
Roshon, Michael [3 ]
Wedoff, Abigail [4 ]
机构：
[1] Centura Hlth St Anthony Hosp, Lakewood, CO USA
[2] St Anthony Hosp, Lakewood, CO USA
[3] Centura Hlth, Centennial, OH USA
[4] Kaiser Permanente Colorado, Denver, CO USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
458
引用
收藏
页码：216 / 216
页数：1
相关论文
共 50 条
  • [1] EVALUATION OF THE EFFICACY OF TOCILIZUMAB IN CRITICALLY ILL COVID-19 PATIENTS
    Riggs, Kayla
    Patel, Vishal
    Pittiglio, Marina
    Cavanaugh, Joseph
    Sullivan, Jesse
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 141 - 141
  • [2] Tocilizumab in critically ill COVID-19 patients: An observational study
    Mushtaq, Muhammad Z.
    Mahmood, Saad B. Z.
    Almas, Aysha
    Wasti, Syed Ather
    Ali, Syed Ahsan
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 102
  • [3] Variants of concern and clinical outcomes in critically ill COVID-19 patients
    [J]. Intensive Care Medicine, 2023, 49 : 697 - 699
  • [4] Variants of concern and clinical outcomes in critically ill COVID-19 patients
    Kurtz, Pedro
    Bastos, Leonardo S. L. T.
    Ranzani, Otavio
    Soares, Marcio
    Zampieri, Fernando
    Hamacher, Silvio
    Salluh, Jorge A.
    Bozza, Fernando
    DP EFFECT BRAZIL investigators
    [J]. INTENSIVE CARE MEDICINE, 2023, 49 (06) : 697 - 699
  • [5] Critically Ill Patients with COVID-19 and AKI: Clinical Characteristics and Outcomes
    El Mouhayyar, Christopher E.
    Dewald, Jonathan
    Cabrales, Jose
    Tighiouart, Hocine
    Moraco, Andrew H.
    Jaber, Bertrand L.
    Balakrishnan, Vaidyanathapuram
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 63 - 63
  • [6] Efficacy of tocilizumab in critically ill COVID-19 patients: a retrospective cohort
    Sadaf, Sairah
    Bashir, Babar
    Haider, Syeda Sabahat
    Mustafa, Ghulam
    Naqvi, Syed Aushtar Abbas
    [J]. ANAESTHESIA PAIN & INTENSIVE CARE, 2021, 25 (03) : 295 - 302
  • [7] PHARMACOKINETIC INFLUENCE OF TOCILIZUMAB ON MIDAZOLAM IN CRITICALLY ILL PATIENTS WITH COVID-19
    Mefford, Breanne
    Donaldson, Chris
    Bissell, Brittany
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 114 - 114
  • [8] Nutritional risk and clinical outcomes in critically ill adult patients with COVID-19
    Nicolas Martinuzzi, Andres Luciano
    Manzanares, William
    Quesada, Eliana
    Jimena Reberendo, Maria
    Baccaro, Fernando
    Aversa, Irina
    Elisabeth Kecskes, Claudia
    Magnifico, Lorena
    Gonzalez, Victoria
    Bolzicco, Daniela
    Baraglia, Nancy
    Navarrete, Priscila
    Manrique, Ezequiel
    Fernanda Cascaron, Maria
    Dietrich, Ailen
    Asparch, Jesica
    Betiana Peralta, Leticia
    Galletti, Cayetano
    Laura Capria, Maria
    Lombi, Yamila
    Cecilia Rodriguez, Marian
    Ester Luna, Camila
    Pablo Chapela, Sebastian
    [J]. NUTRICION HOSPITALARIA, 2021, 38 (06) : 1119 - 1125
  • [9] CLINICAL FEATURES AND OUTCOMES OF CRITICALLY ILL ELDERLY PATIENTS WITH COVID-19 INFECTION
    Mahdi, Ahmed
    Abouzid, Mahmoud
    Raru, Yonas
    Kumar, Anup
    Aguilar, Rodrigo
    Shweihat, Yousef
    Bandak, Ghassan
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 57 - 57
  • [10] Clinical characteristics and outcomes of critically ill COVID-19 patients in Sfax, Tunisia
    Bahloul, Mabrouk
    Kharrat, Sana
    Chtara, Kamilia
    Hafdhi, Malek
    Turki, Olfa
    Baccouche, Najeh
    Ammar, Rania
    Kallel, Nozha
    Hsairi, Majdi
    Chakroun-Walha, Olfa
    Ben Hamida, Chokri
    Chelly, Hedi
    Ben Mahfoudh, Khaiereddine
    Karoui, Abelhamid
    Karray, Hela
    Rekik, Noureddine
    Bouaziz, Mounir
    [J]. ACUTE AND CRITICAL CARE, 2022, 37 (01) : 84 - 93
12345